logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Clínica Universidad de Navarra

+34913531920
cun@unav.es
Source: Site record.
https://www.cun.es

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Clínica Universidad de Navarra is a medical and hospital center characterized by its high degree of medical specialization, continuous technological advancement, and teamwork, enabling a multidisciplinary and personalized assessment of each patient.Founded in 1962, it is part of the University of Navarra. As a result, its research, teaching, and patient care activities are carried out in collaboration with the Schools of Medicine, Sciences, and Pharmacy, the School of Nursing, and the Center for Applied Medical Research (CIMA).

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Trial-derived.
35Total Trials
Source: Trial-derived.
10Recruiting Trials
Source: Trial-derived.
25Active Trials
Source: Trial-derived.
9Completed Trials
Source: Trial-derived.
66Unique Conditions
Source: Trial-derived.
40Unique Sponsors

Conditions

Source: Trial-derived. Advanced Solid Tumors (3)Source: Trial-derived. Hepatocellular Carcinoma (2)Source: Trial-derived. Hypercholesterolemia (2)Source: Trial-derived. Acute Lymphoblastic Leukemia (1)Source: Trial-derived. Acute Myeloid Leukemia (AML) (1)Source: Trial-derived. Acute Pulmonary Embolism (1)Source: Trial-derived. Adenocarcinoma, Pancreatic Ductal (1)Source: Trial-derived. Advanced Melanoma (1)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (6)Source: Trial-derived. Anavex Germany GmbH (2)Source: Trial-derived. Anavex Life Sciences Corp. (2)Source: Trial-derived. Bayer (2)Source: Trial-derived. Daiichi Sankyo (2)Source: Trial-derived. Janssen Research & Development, LLC (2)Source: Trial-derived. AbbVie (1)Source: Trial-derived. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. Echocardiography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Flow Cytometry

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Bone marrow biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. BRAF V600 mutation testing
Source: AI-inferred. Ex vivo stimulation cytokine assay
Source: AI-inferred. HLA-A*02:01 typing
Source: AI-inferred. Minimal residual disease testing
Source: AI-inferred. Plasma neurodegeneration biomarker testing (GFAP, NFL)
Source: AI-inferred. Post-void residual urine volume measurement
Source: AI-inferred. Tumour PD-L1 expression testing
Source: AI-inferred. Uroflowmetry